Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

No longer available × Expanded_access × Lymphangioma × Clear all

Status

No longer available 1

Sponsor Class

Study Type

Expanded_access 1

Sponsor

Conditions

Multiple Myeloma 17 Melanoma 16 Prostatic Neoplasms 14 Neoplasms 13 Recurrence 12 Leukemia, Myeloid, Acute 11 Glioblastoma 9 Carcinoma, Non-Small-Cell Lung 9 Lymphoma 8 Precursor Cell Lymphoblastic Leukemia-Lymphoma 7 Breast Neoplasms 7 Neuroblastoma 6 Leukemia 6 Sarcoma 5 Pancreatic Neoplasms 5 Lymphoma, Non-Hodgkin 5 Lung Neoplasms 5 Glioma 5 Colorectal Neoplasms 5 Carcinoma, Hepatocellular 5 Triple Negative Breast Neoplasms 4 Neuroendocrine Tumors 4 Liver Neoplasms 4 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4 Lambert-Eaton Myasthenic Syndrome 4 Hodgkin Disease 4 Carcinoma, Renal Cell 4 Pheochromocytoma 3 Neoplasm Metastasis 3 Gastrointestinal Stromal Tumors 3

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03941782 2024-01-11

Compassionate Use of BYL 719 Alpelisib

New Mexico Cancer Research Alliance

No longer available

Lymphangioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡